Recommendations and consensus on the treatment of peritoneal metastases of colorectal origin: a systematic review of national and international guidelines-Reference-Cited by-同舟云学术

Recommendations and consensus on the treatment of peritoneal metastases of colorectal origin: a systematic review of national and international guidelines

Published:2017-03 Issue:3 Volume:19 Page:224-236
ISSN:1462-8910
Container-title:Colorectal Disease
language:en
Short-container-title:Colorectal Dis

Author:

Klaver C. E. L.¹,Groenen H.¹,Morton D. G.²,Laurberg S.³,Bemelman W. A.¹,Tanis P. J.¹,

Affiliation:

1. Department of Surgery; Academic Medical Centre; University of Amsterdam; Amsterdam The Netherlands

2. Academic Department of Surgery; University of Birmingham; Edgbaston Birmingham UK

3. Department of Surgical Gastroenterology; Aarhus University; Aarhus C Denmark

Publisher

Wiley

Subject

Gastroenterology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/codi.13593/fullpdf

Reference93 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2014

2. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study;Lemmens;Int J Cancer,2011

3. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer;Segelman;Br J Surg,2012

4. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies;Koppe;Ann Surg,2006

5. Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective Peritoneal Surface Disease Severity Score (PSDSS) for peritoneal carcinomatosis of colorectal origin;Pelz;BMC Cancer,2010

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An observational cohort of patients with colorectal peritoneal metastases or pseudomyxoma peritonei treated with CRS-HIPEC: Development and first results of the Dutch CRS-HIPEC quality registry;European Journal of Surgical Oncology;2024-12

2. Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still beneficial in patients with colorectal peritoneal metastasis who undergoing palliative chemotherapy?;Asian Journal of Surgery;2024-01

3. International Expert Consensus on Defining Textbook Oncologic Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastasis;Journal of the American College of Surgeons;2023-12-27

4. Actual 5-Year Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis of Colorectal Origin;Annals of Surgical Oncology;2023-11-21

5. Adoption of cytoreductive surgery in the management of peritoneal malignancies—Global trends;Journal of Surgical Oncology;2023-10-11